Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page Not Available ()Premium Content



2015-03-04@20:47:07 ET
Fennec Pharmaceuticals Inc.Corporate Event Announcement Notice (WSH)

2015-03-03@20:49:56 ET
Fennec Pharmaceuticals Inc.Corporate Event Announcement Notice (WSH)

2015-02-16@11:36:48 ET
2015Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics (MTO)

2015-02-10@18:32:39 ET
8-K: Actavis plc (EDK)

2015-02-02@08:02:59 ET
Fennec Pharmaceuticals Announces That the Independent Data Monitoring Committee (IDMC) Recommends the Continuation of SIOPEL 6 Phase 3 Clinical Trial (INW)

2015-02-02@08:00:18 ET
Fennec Pharmaceuticals Announces That the Independent Data Monitoring Committee (IDMC) Recommends the Continuation of SIOPEL 6 Phase 3 Clinical Trial (CCN)

2015-01-11@19:00:05 ET
Adamas Pharmaceuticals Provides Review of 2014 and Previews Upcoming Business Drivers (PMZ)

2015-01-09@07:25:26 ET
Adamas Pharmaceuticals wins USD30m milestone payment from Actavis for Namzaric (MTO)

2015-01-08@16:06:47 ET
Adamas Pharmaceuticals Receives $30 Million Milestone Payment From Actavis (PMZ)

2015-01-05@09:03:38 ET
Fennec Pharmaceuticals Announces Completion of Patient Enrollment in Sodium Thiosulfate Phase 3 SIOPEL 6 Study (INW)

2015-01-05@09:00:29 ET
Fennec Pharmaceuticals Announces Completion of Patient Enrollment in Sodium Thiosulfate Phase 3 SIOPEL 6 Study (CCN)

2014-12-24@20:44:09 ET
Fennec Pharmaceuticals Inc.Corporate Event Announcement Notice (WSH)

2014-12-23@20:46:39 ET
Fennec Pharmaceuticals Inc.Corporate Event Announcement Notice (WSH)

2014-12-13@20:40:14 ET
Fennec Pharmaceuticals Inc.Corporate Event Announcement Notice (WSH)

2014-12-12@20:41:55 ET
Fennec Pharmaceuticals Inc.Corporate Event Announcement Notice (WSH)

2014-12-03@09:44:30 ET
Fennec Announces Private Placement of Units (INW)

2014-12-03@09:43:50 ET
Fennec Announces Private Placement of Units (CCN)

2014-12-03@09:24:38 ET
SCYNEXIS, Inc. Announces Appointment of Two Seasoned Industry Professionals to Its Board of Directors (PMZ)

2014-12-03@05:39:56 ET
"Chinese generics market has no strategy for international players" (ABW)

2014-12-03@05:05:05 ET
Grunenthal announces termination of license agreement with Actavis (DTM)